Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
Holding ERNA?
Track your performance easily
ERNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.22 - $2.63
Previous Close$0.34
Volume440.10K
Average Volume (3M)21.71M
Market Cap
$23.07M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.63M
Total Debt (Recent Filing)$1.91M
Price to Earnings (P/E)―
Beta1.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.31
Shares Outstanding51,374,714
10 Day Avg. Volume60,437,993
30 Day Avg. Volume21,705,244
Standard Deviation1.64
R-Squared0.02
Alpha0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)39.98
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eterna Therapeutics News
PremiumMarket News
3 Penny Stocks to Watch Now, 1/16/25
PremiumCompany Announcements
Eterna Therapeutics Faces Nasdaq Compliance and Board Changes
Ownership Overview
42.36% Insiders
0.09% Mutual Funds
0.52% Other Institutional Investors
56.98% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ERNA FAQ
What was Eterna Therapeutics’s price range in the past 12 months?
Eterna Therapeutics lowest stock price was $0.22 and its highest was $2.63 in the past 12 months.
What is Eterna Therapeutics’s market cap?
Eterna Therapeutics’s market cap is $23.07M.
When is Eterna Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eterna Therapeutics’s earnings last quarter?
Eterna Therapeutics released its earnings results on Nov 08, 2022. The company reported -$2.488 earnings per share for the quarter, missing the consensus estimate of -$2.2 by -$0.288.
Is Eterna Therapeutics overvalued?
According to Wall Street analysts Eterna Therapeutics’s price is currently Overvalued.
Does Eterna Therapeutics pay dividends?
Eterna Therapeutics does not currently pay dividends.
What is Eterna Therapeutics’s EPS estimate?
Eterna Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eterna Therapeutics have?
Eterna Therapeutics has 51,374,714 shares outstanding.
What happened to Eterna Therapeutics’s price movement after its last earnings report?
Eterna Therapeutics reported an EPS of -$2.488 in its last earnings report, missing expectations of -$2.2. Following the earnings report the stock price went up 3.67%.
Which hedge fund is a major shareholder of Eterna Therapeutics?
Currently, no hedge funds are holding shares in ERNA
---
Company Description
Eterna Therapeutics
NTN Buzztime, Inc. engages in the provision of entertainment and innovative technology services. It offers entertainment, live events, dining, marketing, hardware, and pricing products. It also includes performance analytics and secure payment with Europay, MasterCard, and Visa chip readers or with near-field communication (NFC) technology to accept Apple, Android, and Samsung Pay. The company was founded in 1984 and is headquartered in Carlsbad, CA.
---
Technical Analysis
Adaptimmune Therapeutics
―
Cardiff Oncology
―
Gritstone bio
―
Kala Pharmaceuticals
―
Bluebird Bio
―
---